Appendix 3B - Proposed issue of securitiesAppendix 3B - Proposed issue of securities1 / 4Announcement SummaryEntity nameARGENT BIOPHARMA LIMITEDAnnouncement TypeNew announcementDate of this announcement29/9/2026The Proposed issue is:Total number of +securities proposed to be issued for a placement...
Proposed issue of securities - RGT
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from Argent Biopharma
- Notification of cessation of securities - RGT
- Appendix 4E and 2026 Annual Report
- Appendix 4G and Corporate Governance Statement
- FDA-CVM Establish INAD File for CannEpil Veterinary Program
- $250,000 in Funding Received under Financing Facility
Later from Argent Biopharma
- Argent Signs NLC Licence to Expand Antiviral Portfolio
- Execution of Loan Facility Agreement
- Application for quotation of securities - RGT
- Strategic Focus on Immune Modulation and Longevity
- Date of AGM and Closing Date for Director Nominations
Follow Argent Biopharma into a list and get an email when it puts out news.
Follow Argent Biopharma